Soltis Investment Advisors LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,486 shares of the company’s stock, valued at approximately $566,000.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Brooklyn Investment Group boosted its position in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new position in Clorox during the 3rd quarter worth $27,000. Continuum Advisory LLC boosted its position in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the period. Carolina Wealth Advisors LLC acquired a new position in Clorox during the 3rd quarter worth $48,000. Finally, Friedenthal Financial acquired a new position in Clorox during the 3rd quarter worth $49,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have issued reports on CLX shares. Barclays boosted their price target on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Evercore ISI upped their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Finally, Wells Fargo & Company upped their price objective on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Clorox presently has a consensus rating of “Hold” and a consensus target price of $158.21.
Clorox Stock Down 0.9 %
Clorox stock opened at $147.08 on Tuesday. The firm has a market capitalization of $18.21 billion, a PE ratio of 40.18, a P/E/G ratio of 2.52 and a beta of 0.42. The company’s 50-day moving average is $161.06 and its 200-day moving average is $159.07. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the company posted $2.16 earnings per share. Sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.32%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 133.33%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Merck: 4 No-Brainer Reasons to Buy This Dip
- 3 Best Fintech Stocks for a Portfolio Boost
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Find Undervalued Stocks
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.